Flex Pharma Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
Flex Pharma (FLKS) Misses Q2 EPS by 10c
August 5, 2015 7:57 AM EDTFlex Pharma (NASDAQ: FLKS) reported Q2 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Flex Pharma (FLKS) click here.
... More